Article Details

ADMA Biologics' (ADMA) “Buy” Rating Reaffirmed at Maxim Group

Retrieved on: 2019-09-11 12:52:30

Tags for this article:

Click the tags to see associated articles and topics

ADMA Biologics' (ADMA) “Buy” Rating Reaffirmed at Maxim Group. View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc. raised its stake in shares of ADMA Biologics by 47.3% during the second quarter. <b>Vanguard Group</b> Inc. now owns 2,448,253 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up